Oxcarbazepine (300mg)
Selzic 300 Tablet is a potent anticonvulsant and mood-stabilizing medication designed to control partial-onset seizures, prevent abnormal brain electrical activity, and support neurological health.
Stabilizes overactive nerve pathways in the brain to effectively prevent and control partial-onset seizures. Promotes long-term neurological stability, significantly lowering the risk of sudden, disruptive epileptic episodes.
Dizziness, Somnolence (sleepiness), Nausea, Vomiting, Double vision, Fatigue, Headache
Take this tablet orally with or without food, exactly as directed by your healthcare professional. Swallow the tablet whole with a glass of water, and maintain a strict, evenly spaced daily schedule to avoid missing any doses.
Unsafe
Caution
Consult Your Doctor
Caution
Caution
Safe If Prescribed
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
In case of any issue, contact us
E-mail address: support@zeptonow.com
Geddit Convenience Private Limited
Geddit Convenience Private Limited,Unit 601, Sakti Statesman, 6th floor, Green Glen Layout, No.37/301/34/1, SY.No.34, Ibblur Village, Begur Hobli Bangalore, Karnataka-560103 For Support ReachOut : support+geddit@zeptonow.com
TG/MDL/2025-128159
20Th Km, Hosur Road, Electronic City, Bangalore, India - 560 100
India
Eris Lifesciences Limited
36 months
November 2026